In:
Journal of Cellular Physiology, Wiley, Vol. 226, No. 9 ( 2011-09), p. 2338-2349
Abstract:
Honokiol (HNK) is a phenolic compound isolated from the bark of houpu ( Magnolia officinalis ), a plant widely used in traditional Chinese and Japanese medicine. While substantial evidence indicates that HNK possesses anti‐inflammatory activity, its effect on dendritic cells (DCs) during the inflammatory reaction remains unclear. The present study investigates how HNK affects lipopolysaccharide (LPS)‐stimulated human monocyte‐derived DCs. Our experimental results show that HNK inhibits the inflammatory response of LPS‐induced DCs by (1) suppressing the expression of CD11c, CD40, CD80, CD83, CD86, and MHC‐II on LPS‐activated DCs, (2) reducing the production of TNF‐α, IL‐1β, IL‐6, and IL‐12p70 but increasing the production of IL‐10 and TGF‐β1 by LPS‐activated DCs, (3) inhibiting the LPS‐induced DC‐elicited allogeneic T‐cell proliferation, and (4) shifting the LPS‐induced DC‐driven Th1 response toward a Th2 response. Further, our results show that HNK inhibits the phosphorylation levels of ERK1/2, p38, JNK1/2, IKKα, and IκBα in LPS‐activated DCs. Collectively, the findings show that the anti‐inflammatory actions of HNK on LPS‐induced DCs are associated with the NF‐κB and mitogen‐activated protein kinase (MAPK) signaling pathways. J. Cell. Physiol. 226: 2338–2349, 2011. © 2010 Wiley‐Liss, Inc.
Type of Medium:
Online Resource
ISSN:
0021-9541
,
1097-4652
Language:
English
Publisher:
Wiley
Publication Date:
2011
detail.hit.zdb_id:
1478143-8
SSG:
12
Permalink